Skip to main content

and
  1. No Access

    Article

    Comparison of haploidentical–allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study

    A retrospective analysis was conducted based on the clinical data from 60 patients older than 16 years from January 2016 to January 2021. All the patients were newly diagnosed with severe aplastic anemia (SAA)...

    Li-qiang Wu, Li-fang Huang, Hui Yang, Bao-dong Ye, Jian-** Sheng in Annals of Hematology (2023)

  2. No Access

    Article

    Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients

    The use of Bcl-2 inhibitor Venetoclax (VEN) combined with hypomethylating agents or chemotherapy has shown efficacy in treating acute myeloid leukemia (AML) as frontline treatment and for relapse, allowing mor...

    Ting-Ting Yang, **ao-Lu Song, Yan-Min Zhao, Bao-Dong Ye, Yi Luo in Annals of Hematology (2022)

  3. No Access

    Article

    Effect of Chinese medicine treatment based on pattern identification on cellular immunophenotype of myelodysplastic syndrome

    To observe the influence of treatment based on Chinese medicine pattern identification on cellular immunophenotype of the myelodysplastic syndrome (MDS).

    Yu Zhang, Li-li Qian, Jian-** Shen in Chinese Journal of Integrative Medicine (2017)